Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease

NCT00816166 is registered in ClinicalTrials.gov with Codman & Shurtleff as lead sponsor.

NCT NCT00816166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00816166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease
Lead sponsor
Codman & Shurtleff
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2008
Completion date
June 30, 2014
Enrollment
125 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, transient ischemic attack